ro-948
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 15, 2022 (NCT06731842)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05464368 | Phase 1 | Aug 31, 2022 | Roche, Washington University in St. Louis |
| NCT06731842 | N/A | May 15, 2022 | Karolinska Institute |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Karolinska Institute | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Roche | For profit | 1 | 0 | 1 | 2022 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1